NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novo Nordisk A/S's quarterly cash and cash equivalents increased from Jun. 2013 ($1,416 Mil) to Sep. 2013 ($1,725 Mil) and increased from Sep. 2013 ($1,725 Mil) to Dec. 2013 ($2,000 Mil).
Novo Nordisk A/S's annual cash and cash equivalents declined from Dec. 2011 ($2,328 Mil) to Dec. 2012 ($2,060 Mil) and declined from Dec. 2012 ($2,060 Mil) to Dec. 2013 ($2,000 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Novo Nordisk A/S Annual Data
Novo Nordisk A/S Quarterly Data